About GATA3, HNF3A, and XBP1, three genes co-expressed with the oestrogen receptor-alpha gene (ESR1) in breast cancer
about
sameAs
Expression of FOXA1 and GATA-3 in breast cancer: the prognostic significance in hormone receptor-negative tumoursTargeting androgen receptor in estrogen receptor-negative breast cancerPioneer transcription factors: establishing competence for gene expressionEpigenetic switch involved in activation of pioneer factor FOXA1-dependent enhancersFoxA1 translates epigenetic signatures into enhancer-driven lineage-specific transcriptionPrognosis of hormone-dependent breast cancers: implications of the presence of dysfunctional transcriptional networks activated by insulin via the immune transcription factor T-betGene expression meta-analysis supports existence of molecular apocrine breast cancer with a role for androgen receptor and implies interactions with ErbB familyDigital quantification of gene expression in sequential breast cancer biopsies reveals activation of an immune responseInfrequent loss of luminal differentiation in ductal breast cancer metastasisIdentification of prognostic signatures in breast cancer microarray data using Bayesian techniques.Discovery and validation of breast cancer subtypesA mouse model for luminal epithelial like ER positive subtype of human breast cancer.TranscriptomeBrowser: a powerful and flexible toolbox to explore productively the transcriptional landscape of the Gene Expression Omnibus databaseMMTV-Espl1 transgenic mice develop aneuploid, estrogen receptor alpha (ERα)-positive mammary adenocarcinomas.Integrative analysis of copy number and gene expression in breast cancer using formalin-fixed paraffin-embedded core biopsy tissue: a feasibility study.Relationships of ESR1 and XBP1 expression in human breast carcinoma and stromal cells isolated by laser capture microdissection compared to intact breast cancer tissue.Maximizing biomarker discovery by minimizing gene signatures.Absent, small or homeotic 2-like protein (ASH2L) enhances the transcription of the estrogen receptor α gene through GATA-binding protein 3 (GATA3).FOXA1 as a therapeutic target for breast cancer.NF-κB signaling is required for XBP1 (unspliced and spliced)-mediated effects on antiestrogen responsiveness and cell fate decisions in breast cancerComparison and identification of estrogen-receptor related gene expression profiles in breast cancer of different ethnic originsA cell-type-specific transcriptional network required for estrogen regulation of cyclin D1 and cell cycle progression in breast cancer.The proteasome inhibitor bortezomib induces an inhibitory chromatin environment at a distal enhancer of the estrogen receptor-α gene.ER-α36-mediated rapid estrogen signaling positively regulates ER-positive breast cancer stem/progenitor cellsLrig1 is an estrogen-regulated growth suppressor and correlates with longer relapse-free survival in ERα-positive breast cancer.Unfolding the Role of Stress Response Signaling in Endocrine Resistant Breast Cancers.A network-based, integrative study to identify core biological pathways that drive breast cancer clinical subtypesEstrogen-induced aurora kinase-A (AURKA) gene expression is activated by GATA-3 in estrogen receptor-positive breast cancer cells.Estrogenic regulation of S6K1 expression creates a positive regulatory loop in control of breast cancer cell proliferationGenomic antagonism between retinoic acid and estrogen signaling in breast cancer.Molecular portraits revealing the heterogeneity of breast tumor subtypes defined using immunohistochemistry markers.Endocrine resistance in breast cancer--An overview and update.Orphan nuclear receptors in breast cancer pathogenesis and therapeutic response.bc-GenExMiner 3.0: new mining module computes breast cancer gene expression correlation analysesGenomic analysis of estrogen cascade reveals histone variant H2A.Z associated with breast cancer progression.Histone H3 lysine 4 acetylation and methylation dynamics define breast cancer subtypesDiagnostic SOX10 gene signatures in salivary adenoid cystic and breast basal-like carcinomas.Genetic ablation of caveolin-1 drives estrogen-hypersensitivity and the development of DCIS-like mammary lesions.Log-Linear Models for Gene Association.Profile of estrogen-responsive genes in an estrogen-specific mammary gland outgrowth model.
P2860
Q21030553-1C61393C-1910-4D66-A65F-AB442986E77FQ24312457-03BEF1CD-EA03-4939-90AB-998B28E004FFQ24625373-7403C461-A9D1-4FF3-B96E-1BE604C18068Q24630926-621B9355-6F8D-4B74-B0D9-D53F1E1BD055Q24645118-1D2B6CD1-4FB1-4AFB-BD55-1CBEB4A16074Q24645449-267CDAB5-D31A-482E-8CC2-46A5623373C5Q28258227-25807AD7-B2D4-4E02-A734-7449BF1B6C0DQ28533543-5435A452-DF91-42B1-8B54-AE94675CEB59Q28534555-0ED2ECC2-9B5F-4295-865C-8A32F5063BD1Q31049076-EC23B6B6-8435-4244-80F7-BC1366B9ACB2Q33257139-765FF137-410E-4080-97E4-0645499ED4D6Q33299625-4DF02734-9CB5-4527-886D-9DF1928EE071Q33395340-37A0C0F2-E5CA-49A2-A055-F4E53D44078EQ33657478-6D65CA0F-4EF1-424F-A00A-5E7D862E0572Q33896397-6B27648F-9F82-4422-BD10-6D226D30687DQ34000269-E5530AA5-5584-47CC-8EF1-77DEF98983FAQ34173408-C12F4EFE-01A7-4EC3-AC48-6E59890FF9B4Q34467617-89F572D3-B883-4B4E-AC7B-E79E2AC25BD0Q34610510-3CE29FD5-8E42-4B60-B099-423BF5F96178Q34745409-2A0A1432-891E-4433-89CA-2F7E7CE9534DQ34965545-C7C45E9F-AE81-483C-9526-C8D1DC856A02Q35052559-4958931A-D47E-40E9-B21F-27A6D5AEDD72Q35067415-382CD0C7-6FB4-48A0-A9A6-EFB3932E25A7Q35099499-191B73E3-5C0A-4251-BEDE-1B0FF183D846Q35386137-ED539A5E-86A8-450A-AA1E-B7A8819A26C7Q35763853-67971E14-FD2B-4775-A007-469755256705Q35832269-2CB99DA2-BB8A-43C8-BD1D-1FE91E4C2171Q35850229-7375C619-F2A6-4742-AD67-3A5BA149CF2CQ35928654-AD4154A9-CC92-413E-B1E7-546CDCB21A7BQ36028691-8F94C4B1-355D-4074-A058-8C1DD727FE07Q36099968-F6004106-4773-4D03-9B9E-863C5EF924EFQ36386322-F8451497-AAE2-4BC9-8BFA-E5F029A3073CQ36455407-6F4D55F0-5075-43D3-9CBB-33F4ED969482Q36543286-20FFB91E-23B1-49C0-8CBB-DCF880CBC21AQ36671809-DE3B1A0C-9DBB-440A-BEA4-6FB6C259A9A4Q36905610-D570D292-E3DD-4E6A-B0A6-AD8FB04621E9Q37040627-8D99784F-62D9-4DA6-846E-652B26A92EA3Q37164504-7118CEA6-B188-4E9D-BD9A-3365F32B0F51Q37286532-1A5D963A-7780-4BBE-B6A7-2A6D9F48C625Q37331776-783259B7-671E-45B2-B3E4-8DBBEA3DE2E0
P2860
About GATA3, HNF3A, and XBP1, three genes co-expressed with the oestrogen receptor-alpha gene (ESR1) in breast cancer
description
2004 nî lūn-bûn
@nan
2004 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2004 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
name
About GATA3, HNF3A, and XBP1, ...... a gene (ESR1) in breast cancer
@ast
About GATA3, HNF3A, and XBP1, ...... a gene (ESR1) in breast cancer
@en
About GATA3, HNF3A, and XBP1, ...... a gene (ESR1) in breast cancer
@nl
type
label
About GATA3, HNF3A, and XBP1, ...... a gene (ESR1) in breast cancer
@ast
About GATA3, HNF3A, and XBP1, ...... a gene (ESR1) in breast cancer
@en
About GATA3, HNF3A, and XBP1, ...... a gene (ESR1) in breast cancer
@nl
altLabel
About GATA3, HNF3A, and XBP1, ...... α gene (ESR1) in breast cancer
@en
prefLabel
About GATA3, HNF3A, and XBP1, ...... a gene (ESR1) in breast cancer
@ast
About GATA3, HNF3A, and XBP1, ...... a gene (ESR1) in breast cancer
@en
About GATA3, HNF3A, and XBP1, ...... a gene (ESR1) in breast cancer
@nl
P1476
About GATA3, HNF3A, and XBP1, ...... a gene (ESR1) in breast cancer
@en
About GATA3, HNF3A, and XBP1, ...... α gene (ESR1) in breast cancer
@en
P2093
P356
10.1016/J.MCE.2004.02.021
10.1016/S0303-7207(04)00099-1
P407
P577
2004-04-01T00:00:00Z
2004-04-30T00:00:00Z